Trademark Overview
On Thursday, September 12, 2024, a trademark application was filed for HIZENTRA with the United States Patent and Trademark Office. The USPTO has given the HIZENTRA trademark a serial number of 98746950. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, September 12, 2024. This trademark is owned by CSL Behring AG. The HIZENTRA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of immuno deficiency disorders; intravenous immunoglobulins for use in the treatment of immuno deficiency disorders and in immune replacement therapy; Pharmaceutical preparations for the treatment of dermatomyositis, inflammatory diseases and inflammatory conditions, muscle conditions and skin conditions, pharmaceutical preparations for the treatment of skin rash, weight loss, fever, lung conditions, light sensitivity, calcium deposits, and cardiovascular conditions; pharmaceutical preparations for the treatment of inflammatory myopathy and muscular conditions
